| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 13.139 | 37.973 | 43.464 | 55.645 | 62.080 | 66.430 | 76.162 | 98.676 | 126.693 |
| Total Income - EUR | - | 13.139 | 37.974 | 43.466 | 55.645 | 64.157 | 66.430 | 76.162 | 98.686 | 126.716 |
| Total Expenses - EUR | - | 3.549 | 22.126 | 26.831 | 30.625 | 30.976 | 34.285 | 32.087 | 24.831 | 25.822 |
| Gross Profit/Loss - EUR | - | 9.591 | 15.849 | 16.635 | 25.020 | 33.181 | 32.144 | 44.075 | 73.855 | 100.893 |
| Net Profit/Loss - EUR | - | 9.328 | 15.469 | 16.200 | 24.463 | 32.605 | 31.480 | 43.313 | 72.868 | 97.092 |
| Employees | - | 1 | 3 | 3 | 3 | 3 | 3 | 2 | 1 | 1 |
Check the financial reports for the company - Versamedic Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 2.880 | 3.363 | 3.066 | 4.297 | 35.921 | 36.929 | 43.558 | 43.500 |
| Current Assets | - | 10.277 | 14.064 | 26.698 | 38.562 | 34.259 | 27.292 | 7.354 | 64.882 | 55.468 |
| Inventories | - | 307 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 249 | 1.899 | 0 | 2.107 | 15.038 | 870 | 5.411 | 8.788 | 52.007 |
| Cash | - | 9.720 | 12.165 | 26.698 | 36.454 | 19.221 | 26.422 | 1.944 | 56.095 | 3.461 |
| Shareholders Funds | - | 9.372 | 15.521 | 27.156 | 40.620 | 36.896 | 56.829 | 43.435 | 103.940 | 97.213 |
| Social Capital | - | 45 | 44 | 43 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | - | 904 | 1.423 | 2.904 | 1.007 | 1.659 | 6.384 | 848 | 4.501 | 1.756 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Versamedic Srl